JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Probing the Inhibitory Potential of Halogenated Symmetrical Formamidine Against MAO-A and MAO-B: Structural Elucidation, Molecular Dynamic Simulation and DFT Computational Studies

  • 0Department of Chemistry and Polymer Science, Stellenbosch University, Matieland, South Africa.
Chemistry & biodiversity +

|

June 13, 2025

Abstract

A halogenated symmetrical formamidine, N,N'-bis(3-chloro-4-fluorophenyl)formamidine (FCF) was synthesized by the condensation reaction between triethyl orthoformate and 3-chloro-4-fluoroaniline in 1:2 ratio. The compound FCF was characterized by FT-IR, mass, NMR (1H and 13C) spectroscopic techniques and the purity was confirmed by elemental analysis. Crystal structural elucidation of FCF showed that it conformed to an E-anti-molecular isomer. In the crystal packing system of FCF, there exists N─H⋯N hydrogen bonding intermolecular interactions between the azomethine nitrogen (N-azomethine) and amine hydrogen (H-amine) atoms of neighboring molecules resulting in the formation of dimers with an R 2 2 $\frac{2}{2}$ 8 graph set motif. Hirshfeld surface analysis unraveled that, H⋯H and Cl⋯H intermolecular contacts contributed equally and the most with each of them contributing 14.6% in crystal packing. The geometrical and electronic properties of FCF were investigated using DFT/B3LYP/6-311++G(d,p) basis sets. Mulliken and MESP analyses identified reactive sites, while FMO studies revealed a HOMO-LUMO gap (4.62 eV) indicative of intermediate reactivity and stability. Molecular docking and molecular dynamics simulations (MDS) were performed to evaluate the inhibitory potential of FCF against monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B), both are protein targets for managing Parkinson's disease. Docking studies revealed that FCF exhibited superior binding affinity towards both MAO-A and MAO-B compared to the reference drugs (harmine and rasagiline) as reflected in its more negative docking scores. MDS analysis was conducted over 100 ns and we found out that FCF demonstrated superior inhibitory potential against MAO-A and MAO-B compared to the reference drugs, as indicated by its stronger binding free energies (-38.78 ± 2.62 kcal mol-1 for MAO-A and -34.15 ± 3.29 kcal mol-1 for MAO-B) relative to harmine (-32.43 ± 2.26 kcal mol-1) and rasagiline (-32.44 ± 2.65 kcal mol-1). Furthermore, MDS analysis also confirmed the stability of FCF-protein complexes, with lower RMSD values suggesting greater structural stability. In addition, pharmacokinetic analysis revealed that FCF possesses favorable drug-like properties, including high gastrointestinal absorption, blood-brain barrier permeability, and a nontoxic profile, reinforcing its potential as a promising therapeutic agent for targeting neurodegenerative disorders such as Parkinson's disease.

Related Concept Videos

<em data-lazy-src=

5.5K

Halogens are ortho–para directors. They are more electronegative than carbon. Therefore, as ring substituents, they can withdraw electrons through the inductive effect and deactivate the aromatic ring towards electrophilic substitution. Halogens also have an electron-donating resonance effect on the ring, which influences the orientation of the incoming electrophile. If an electrophile attacks at the ortho or the para position, the halogen donates electrons and stabilizes the intermediate...

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship 01:29

543

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...

Drugs Affecting Neurotransmitter Synthesis 01:29

1.3K

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...

Drugs Affecting Neurotransmitter Release or Uptake 01:21

1.0K

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...

Indirect-Acting Cholinergic Agonists: Mechanism of Action 01:18

1.8K

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...

Antidepressant Drugs: MAOIs and Other Agents 01:23

205

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...